Александр Панчин - Сумма биотехнологии. Руководство по борьбе с мифами о генетической модификации растений, животных и людей

496. Takahashi K., Yamanaka S.: Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126(4):663–76.

497. Zhong X.Y. et al.: Umbilical cord blood stem cells: what to expect. Ann NY Acad Sci 2010, 1205:17–22.

498. Xiao N. et al.: Co-transplantation of mesenchymal stromal cells and cord blood cells in treatment of diabetes. Cytotherapy 2013, 15(11):1374–84.

499. Wang D. et al.: Allogeneic mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus: 4 years of experience. Cell Transplant 2013, 22(12):2267–77.

500. Liu J. et al.: Clinical analysis of the treatment of spinal cord injury with umbilical cord mesenchymal stem cells. Cytotherapy 2013, 15(2):185–91.

501. Canavero S.: The “Gemini” spinal cord fusion protocol: Reloaded. Surg Neurol Int 2015, 6:18.

502. Behringer W. et al.: Survival without brain damage after clinical death of 60–120 mins in dogs using suspended animation by profound hypothermia. Crit Care Med 2003, 31(5):1523–31.

503. Balaban E.: Brain switching: studying evolutionary behavioral changes in the context of individual brain development. Int J Dev Biol 2005, 49(2–3):117–24.

504. Estrada V. et al.: Long-lasting significant functional improvement in chronic severe spinal cord injury following scar resection and polyethylene glycol implantation. Neurobiol Dis 2014, 67:165–79.

505. Breidenbach W.C. et al.: Outcomes of the first 2 American hand transplants at 8 and 6 years posttransplant. J Hand Surg Am 2008, 33(7):1039–47.

506. Minev I.R. et al.: Biomaterials. Electronic dura mater for longterm multimodal neural interfaces. Science 2015, 347(6218):159–63.

507. Soekadar S.R. et al.: An EEG/EOG-based hybrid brain-neural computer interaction (BNCI) system to control an exoskeleton for the paralyzed hand. Biomed Tech (Berl) 2015, 60(3):199–205.

508. Shih J.J. et al.: Brain-computer interfaces in medicine. Mayo Clin Proc 2012, 87(3):268–79.

509. Wissner-Gross A.D., Freer C.E.: Causal entropic forces. Phys Rev Lett 2013, 110(16):168702.

510. Pietschnig J., Voracek M.: One Century of Global IQ Gains: A Formal Meta-Analysis of the Flynn Effect (1909–2013). Perspect Psychol Sci 2015, 10(3):282–306.mm

511. Prescott V.E. et al: Transgenic expression of bean alpha-amylase inhibitor in peas results in altered structure and immunogenicity. J Agric Food Chem 2005,53(23):9023–30.

512. Genetically modified mush. Nat Biotechnol 2006, 24(1):2.

513. Lee R.Y. et al: Genetically modified alpha-amylase inhibitor peas are not specifically allergenic in mice. PLOS ONE 2013, 8(1):e52972.

514. Campbell P.M. et al: Comparison of the alpha-amylase inhibitor-1 from common bean (Phaseolus vulgaris) varieties and transgenic expression in other legumes – post-translational modifications and immunogenicity. J Agric Food Chem 2011, 59(11): 6047–54.